1. Home
  2. NCSM vs LEXX Comparison

NCSM vs LEXX Comparison

Compare NCSM & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

SELL

Current Price

$64.01

Market Cap

170.3M

Sector

Energy

ML Signal

SELL

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.71

Market Cap

16.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
LEXX
Founded
2006
2004
Country
United States
Canada
Employees
N/A
7
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
16.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NCSM
LEXX
Price
$64.01
$0.71
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
19.6K
132.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
239.22
N/A
EPS
8.65
N/A
Revenue
$142,471,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
$7.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.20
$0.46
52 Week High
$68.40
$1.90

Technical Indicators

Market Signals
Indicator
NCSM
LEXX
Relative Strength Index (RSI) 72.38 45.25
Support Level $36.05 $0.58
Resistance Level N/A $0.87
Average True Range (ATR) 3.43 0.08
MACD 2.33 -0.00
Stochastic Oscillator 75.17 20.75

Price Performance

Historical Comparison
NCSM
LEXX

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: